EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic interaction between praziquantel and oxfendazole or fenbendazole in a murine cysticercosis model

Palomares-Alonso Francisca iD, González-Maciel Angélica iD, Reynoso-Robles Rafael, Castro Nelly iD, Pérez-Severiano Francisca iD, Sánchez-Mendoza Alicia iD, Jung-Cook Helgi iD, Bravo Guadalupe iD, López-Muñoz Francisco iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00560-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Palomares-Alonso Francisca und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Neuroinflamación, Instituto Nacional de Neurología y Neurocirugía, Ciudad de México, Mexico. Hauptthemen laut MEDLINE: Praziquantel, Fenbendazole, Anthelmintics, Benzimidazoles. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Up to date, the pharmacological treatment for active neurocysticercosis (NCC) includes only two drugs, praziquantel and albendazole; however, the clinical response is not always successful, due to its low bioavailability; therefore, new approaches are needed. The aim of the present study was to evaluate the pharmacological interaction between praziquantel (PZQ) and oxfendazole (OXF) in vitro ; also, the drug-drug interaction between PZQ and OXF or fenbendazole (FBZ) in vivo using Taenia crassiceps metacestode was assessed. For the in vitro study, the surface of synergistic interaction (SSI) analysis was used to determine the kind of drug interaction between PZQ and OXF. Additionally, morphological and ultrastructural effects were investigated using transmission scanning electron microscopy. For the in vivo study, different doses of PZQ and FBZ or OXF were combined, and the cysticidal effect was determined. In vitro, results showed that 12 combinations exhibited synergism, and four exhibited additive effects. The 1:5 ratio of PZQ and OXF exhibited the highest synergistic effect, with an 11-fold increase in comparison to their theoretical sum. Microscopic observations revealed damage to the tegument and germinal layer; microtriches, flame cells, and muscular fibers were also affected. In vivo, results showed that PZQ + FBZ and PZQ + OXF (ratios 1:4 and 1:1, respectively) exhibited a synergistic reduction of the parasites. The findings of the present study show the potential of these combinations as a pharmacological alternative for cysticercosis treatment. Complementary studies are needed to determine their benefits in the clinical field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PraziquantelFenbendazoleAnthelminticsBenzimidazolesCysticercosisNeurocysticercosisAnimalsDrug SynergismMiceDisease Models, AnimalDrug Therapy, CombinationTaenia

Stichwörter der Autor:innen

fenbendazolemurine cysticercosisoxfendazolepraziquantel and synergistic effect

Substanzen

PraziquanteloxfendazoleFenbendazoleAnthelminticsBenzimidazoles

Autor:innen und Institutionen

  • Laboratorio de Neuroinflamación, Instituto Nacional de Neurología y Neurocirugía, Ciudad de México, Mexico.
  • Laboratorio de Morfología Celular y Tisular, Instituto Nacional de Pediatría, Ciudad de México, Mexico.
  • Laboratorio de Neurobioquímica y Conducta, Instituto Nacional de Neurología y Neurocirugía, Ciudad de México, Mexico.
  • Laboratorio de Neurofarmacología molecular y nanotecnología, Instituto Nacional de Neurología y Neurocirugía, Ciudad de México, Mexico.
  • Departamento de Farmacología, Instituto Nacional de Cardiología, Ciudad de México, Mexico.
  • Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.

ORCID-Profile: Palomares-Alonso Francisca, González-Maciel Angélica, Castro Nelly, Pérez-Severiano Francisca, Sánchez-Mendoza Alicia, Jung-Cook Helgi, Bravo Guadalupe, López-Muñoz Francisco

Zitieren

APA

Francisca, P. A., Angélica, G. M., Rafael, R. R., Nelly, C., Francisca, P. S., Alicia, S. M., Helgi, J. C., Guadalupe, B., & Francisco, L. M. (2025). Synergistic interaction between praziquantel and oxfendazole or fenbendazole in a murine cysticercosis model. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00560-25

Vancouver

Francisca PA, Angélica GM, Rafael RR, Nelly C, Francisca PS, Alicia SM, et al. Synergistic interaction between praziquantel and oxfendazole or fenbendazole in a murine cysticercosis model. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00560-25

BibTeX
@article{Francisca2025,
  author = {Francisca, Palomares-Alonso and Angélica, González-Maciel and Rafael, Reynoso-Robles and Nelly, Castro and Francisca, Pérez-Severiano and Alicia, Sánchez-Mendoza and Helgi, Jung-Cook and Guadalupe, Bravo and Francisco, López-Muñoz},
  title = {Synergistic interaction between praziquantel and oxfendazole or fenbendazole in a murine cysticercosis model},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00560-25}
}
Kostenlos starten →